摘要
As a promising therapeutic target for gout, hURAT1 has attracted increasing attention. In this work, we identified a novel scaffold of hURAT1 inhibitors from a personal natural product database of verified herb-treated gout. First, we constructed more than 800 natural compounds from Chinese medicine that were verified to treat gout. Following the application of both shape-based and docking-based virtual screening (VS) methods, taking into account the shape similarity and flexibility of the target, we identified isopentenyl dihydroflavones that might inhibit hURAT1. Specifically, 9 compounds with commercial availability were tested with biochemical assays for the inhibition of C-14-uric acid uptake in high-expression hURAT1 cells (HEK293-hURAT1), and their structure-activity relationship was evaluated. As a result, 8-isopentenyl dihydroflavone was identified as a novel scaffold of hURAT1 inhibitors since isobavachin (DHF3) inhibited hURAT1 with an IC50 value of 0.39 +/- 0.17 mu M, which was comparable to verinurad with an IC50 value of 0.32 +/- 0.23 mu M. Remarkably, isobavachin also displayed an eminent effect in the decline of serum uric acid in vivo experiments. Taken together, isobavachin is a promising candidate for the treatment of hyperuricemia and gout.
学科与关键词
- Pharmacological evaluation of a novel skeleton compound isobavachin (4?,7-dihydroxy-8-prenylflavanone) as a hypouricemic agent: Dual actions of URAT1/GLUT9 and xanthine oxidase inhibitory activityZhao, Zean; Luo, Jian; Liao, Hui; Zheng, Fengxin; Chen, Xinhua; Luo, Jiajun; Chen, Yongjun; Zhao, Kunlu; Zhang, Shuqin; Tian, Jinhong; Wu, Ting; Li, Yongmei; Li, Lu; Yang, Yang; Lin, Cuiting; Zhang, Qun*; Tian, Yuanxin*; Pang, Jianxin*Bioorganic Chemistry, 2023, 133: 106405.被引 2
- Mechanism of anti-hyperuricemia of isobavachin based on network pharmacology and molecular dockingLuo, Jia-jun; Chen, Xin-hua; Liang, Peng-ying; Zhao, Zean; Wu, Ting; Li, Zhong-huang; Wan, Shan-he; Luo, Jian; Pang, Jian-xin*; Zhang, Jia-jie*; Tian, Yuan-xin*Computers in Biology and Medicine, 2023, 155: 106637.
- Identification of novel dual inhibitors targeting XOR and URAT1 via multiple virtual screening methodsZhu, XinYing; Yang, Chao; Zhang, Lei; Li, Jing*Journal of Molecular Structure, 2022, 1256: 132567.被引 3
